SRPT - Sarepta Therapeutics, Inc.


16.09
0.220   1.367%

Share volume: 2,068,645
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.72%

PREVIOUS CLOSE
CHG
CHG%

$15.87
0.22
0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 06-30-2025 09-30-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Report Date 05-01-2024 08-07-2024 11-06-2024 02-28-2025 05-06-2025 08-06-2025 11-06-2025
Total revenue 413.464 M 362.931 M 467.172 M 658.412 M 744.856 M 611.091 M 399.356 M
Cost of revenue 50.559 M 0.000 0.000 0.000 0.000 0.000 0.000
Gross profit 362.905 M 362.931 M 467.172 M 658.412 M 744.856 M 611.091 M 399.356 M
    0.01% 28.72% 40.94% 13.13% -17.96% -34.65%  
Operating expenses 327.399 M 318.486 M 352.683 M 363.826 M 907.077 M 342.289 M 310.783 M
Selling general and admin 127.003 M 138.796 M 128.200 M 163.873 M 133.629 M 137.897 M 91.893 M
Research and development 200.396 M 179.690 M 224.483 M 199.953 M 773.448 M 204.392 M 218.890 M
Total expenses 378.559 M 363.632 M 444.976 M 496.731 M 1.045 B 495.514 M 502.745 M
    -3.94% 22.37% 11.63% 110.42% -52.59% 1.46%  
Operating income 34.905 M -701.000 K 22.196 M 161.681 M -300.386 M 115.577 M -103.389 M
Ebit 34.905 M 13.577 M 34.006 M 171.743 M -383.518 M 153.638 M -55.436 M
Pretax income 41.448 M 13.577 M 34.006 M 171.743 M -383.518 M 153.638 M -194.049 M
    -67.24% 150.47% 405.04% -323.31% -140.06% -226.30%  
Income tax 5.329 M 7.117 M 395.000 K 12.694 M 63.990 M -43.254 M -14.102 M
Net income basic 36.119 M 0.000 0.000 0.000 0.000 0.000 0.000
    -100.00%            
Net income 36.119 M 6.460 M 33.611 M 159.049 M -447.508 M 196.892 M -179.947 M
    -82.11% 420.29% 373.21% -381.36% 144.00% -191.39%